[Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma].
Wörmann
B
B
Abteilung Hämatologie/Onkologie, Zentrum Innere Medizin, Göttingen.
Unterhalt
M
M
Hiddemann
W
W
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D015182:Lymphatic Irradiation; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011687:Purines / Q000627:therapeutic use; D015996:Survival Rate
D000911:Antibodies, Monoclonal; D016898:Interferon-alpha; D007376:Interleukin-2; D011687:Purines